CHEBI:32140 - sodium caffeine benzoate

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name sodium caffeine benzoate
ChEBI ID CHEBI:32140
Definition A mixture of caffeine and sodium benzoate. It is used for the treatment of acute respiratory depression associated with overdosage of CNS depressant drugs and also used in combination with ergotamine to prevent vascular headaches.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C8H10N4O2.C7H5O2.Na
Net Charge 0
Average Mass 338.299
Monoisotopic Mass 338.09910
InChI InChI=1S/C8H10N4O2.C7H6O2.Na/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2;8-7(9)6-4-2-1-3-5-6;/h4H,1-3H3;1-5H,(H,8,9);/q;;+1/p-1
InChIKey JWBPVFVNISJVEM-UHFFFAOYSA-M
SMILES C12=C(N(C(=O)N(C)C1=O)C)N=CN2C.C1(=CC=CC=C1)C(=O)[O-].[Na+]
ChEBI Ontology
Outgoing sodium caffeine benzoate (CHEBI:32140) has part caffeine (CHEBI:27732)
sodium caffeine benzoate (CHEBI:32140) has part sodium benzoate (CHEBI:113455)
sodium caffeine benzoate (CHEBI:32140) is a mixture (CHEBI:60004)
IUPAC Name
sodium 1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione benzoate
Synonyms Sources
caffeine and sodium benzoate KEGG DRUG
caffeine benzoic acid sodium salt ChEBI
caffeine sodium benzoate ChemIDplus
sodium benzoate and caffeine ChemIDplus
sodium benzoate—1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione IUPAC
sodium caffeine benzoate KEGG COMPOUND
Brand Name Source
Annaca KEGG DRUG
Manual Xrefs Databases
C13403 KEGG COMPOUND
D02409 KEGG DRUG
View more database links
Registry Numbers Types Sources
8000-95-1 CAS Registry Number KEGG COMPOUND
8000-95-1 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
15810401 PubMed citation Europe PMC
29768288 PubMed citation Europe PMC
9952095 PubMed citation Europe PMC
Last Modified
20 February 2019